Data as of Sep 16
| +1.38 / +0.51%|
The 13 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 499.00, with a high estimate of 693.00 and a low estimate of 172.00. The median estimate represents a +84.96% increase from the last price of 269.79.
The current consensus among 13 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.